Studies highlight dynamic impact of COVID-19 on antibiotic use | CIDRAP
USA. 17th Mar, 2022. Person's hand holding a vial of intravenous (IV) antibiotics from Sandoz including piperacillin and tazobactam broad-spectrum antibiotics in a hospital in San Francisco, California, March 17, 2022. Photo
Antibiotic Infusion Therapy: A New Way to Get Better, Sooner
Introduction of an IV antibiotic preparation service during the COVID-19 pandemic
Mix-Ups Between Epidural Analgesia and IV Antibiotics in L&D Units Continue to Cause Harm - Patient Safety & Quality Healthcare